Skip to content
Rio de Janeiro · São Paulo · Salvador — matters across Brazil
Bruno Marcelos — Escritório de Advocacia

Pauta Regulatória · Daily brief

No. 69

Automatically translated from the Portuguese edition, which prevails in case of discrepancy. Ler em português

Federal Official Gazette

No updates.

ANS news

Análise da 2ª reunião técnica extraordinária da Cosaúde

The National Supplementary Health Agency (ANS) held, on Jan 13, the 2nd extraordinary technical meeting of the Commission for the Update of the List of Supplementary Health Procedures and Events (Cosaúde). The meeting aimed to analyze the contributions from society in Public Consultation No. 163 and Public Hearing No. 61 on the inclusion of the drug momelotinib for myelofibrosis (an uncommon type of blood cancer that affects the fibrous tissue of the bone marrow) in the List of Health Procedures and Events (Rol).

Análise da 2ª reunião técnica extraordinária da Cosaúde — Agência Nacional de Saúde Suplementar

Open public consultations

  • CP 165. Its purpose is to receive contributions on the proposed Normative Resolution governing the transfer of portfolios of private health care plans between private health care plan operators. Deadline: Jan 23, 2026.

Scheduled public hearings

There are no public hearings scheduled.

Open public calls for input

  • A Public Call for Input (TPS) is open from December 16, 2025 to January 31, 2026, intended to receive suggestions on the priority supplementary health topics that will inform the composition of the 2026-2028 Regulatory Agenda of the National Supplementary Health Agency (ANS).

Open public calls

No updates.

Other news

Judge upholds price adjustments in group health plan with three people

Source: migalhas.com.br · read the full article

Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.